Athira Pharma (ATHA) Insider Trading & Ownership $0.57 0.00 (0.00%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Athira Pharma (NASDAQ:ATHA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.80%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$100,208.00Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$31,533.97 Get ATHA Insider Trade Alerts Want to know when executives and insiders are buying or selling Athira Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ATHA Insider Buying and Selling by Quarter Athira Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/2/2025Mark James LittonCEOSell25,107$0.56$14,059.92 1/2/2025Mark WorthingtonGeneral CounselSell8,510$0.56$4,765.60 1/2/2025Martin Javier SanInsiderSell10,826$0.56$6,062.56 1/2/2025Robert RenningerVPSell2,881$0.56$1,613.36 9/5/2024Andrew GengosCFOSell1,272$0.57$725.04 9/5/2024Mark James LittonCEOSell5,032$0.57$2,868.24 9/5/2024Rachel LeningtonCOOSell2,525$0.57$1,439.25 6/24/2024Kelly A RomanoDirectorBuy27,400$2.42$66,308.00 6/21/2024Kelly A RomanoDirectorBuy15,000$2.26$33,900.00 (Data available from 1/1/2013 forward) ATHA Insider Trading Activity - Frequently Asked Questions Who is on Athira Pharma's Insider Roster? The list of insiders at Athira Pharma includes Andrew Gengos, Glenna Mileson, Hans Moebius, James A Johnson, Kelly A Romano, Mark James Litton, Mark Worthington, Martin Javier San, Perceptive Advisors Llc, Rachel Lenington, and Robert Renninger. Learn more on insiders at ATHA. What percentage of Athira Pharma stock is owned by insiders? 19.80% of Athira Pharma stock is owned by insiders. Learn more on ATHA's insider holdings. Which Athira Pharma insiders have been buying company stock? The following insiders have purchased ATHA shares in the last 24 months: Andrew Gengos ($242,883.84), James A Johnson ($12,000.00), Kelly A Romano ($100,208.00), and Perceptive Advisors Llc ($463,476.04). How much insider buying is happening at Athira Pharma? Insiders have purchased a total of 323,500 ATHA shares in the last 24 months for a total of $818,567.88 bought. Which Athira Pharma insiders have been selling company stock? The following insiders have sold ATHA shares in the last 24 months: Andrew Gengos ($4,240.32), Mark James Litton ($30,954.36), Mark Worthington ($11,784.52), Martin Javier San ($6,062.56), Rachel Lenington ($1,439.25), and Robert Renninger ($1,613.36). How much insider selling is happening at Athira Pharma? Insiders have sold a total of 64,593 Athira Pharma shares in the last 24 months for a total of $56,094.37 sold. Athira Pharma Key ExecutivesDr. Mark J. Litton M.B.A. (Age 56)Ph.D., President, CEO & Director Compensation: $882.7kMr. Andrew W. Gengos (Age 60)CFO & Chief Business Officer Compensation: $396.16k1 recent tradesMs. Rachel P. Lenington M.B.A. (Age 51)Chief Development Officer & COO Compensation: $578kDr. Kevin Church Ph.D. (Age 39)Chief Scientific Officer Compensation: $123.67kMs. Julie RathbunHead of Investor RelationsMr. Mark F. Worthington J.D. (Age 58)General Counsel & Corporate Secretary Compensation: $503.83k1 recent tradesMs. Samantha WillingChief People OfficerDr. Javier San Martin M.D. (Age 59)Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies UNCY Insider Trading ASRT Insider Trading GNLX Insider Trading QNCX Insider Trading ANIX Insider Trading EPIX Insider Trading DERM Insider Trading CTMX Insider Trading AVTX Insider Trading ATRA Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop BuyingAppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? This page (NASDAQ:ATHA) was last updated on 1/6/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$24 trillion tech spotted at Mar-a-Lago?President Trump’s Secret Service was recently spotted using an odd new technology at his home in Mar-a-Lago…Centurion Publishing | SponsoredFrom bankrupt to delivering 610,000% returnsWalk the empty streets of this barren town and you would have no idea that behind the sand-scarred blight is o...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athira Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athira Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
